<div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Naloxone
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Chemical</span>
</mark>
 reverses the antihypertensive effect of 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    clonidine
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Chemical</span>
</mark>
. In unanesthetized, spontaneously 
<mark class="entity" style="background: linear-gradient(90deg, #fca9a9, #fcd59c); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    hypertensive
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Disease</span>
</mark>
 rats the decrease in blood pressure and heart rate produced by intravenous 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    clonidine
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Chemical</span>
</mark>
, 5 to 20 micrograms/kg, was inhibited or reversed by 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nalozone
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Chemical</span>
</mark>
, 0.2 to 2 mg/kg. The 
<mark class="entity" style="background: linear-gradient(90deg, #fca9a9, #fcd59c); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    hypotensive
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Disease</span>
</mark>
 effect of 100 mg/kg 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    alpha-methyldopa
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Chemical</span>
</mark>
 was also partially reversed by 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    naloxone
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Chemical</span>
</mark>
. 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Naloxone
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Chemical</span>
</mark>
 alone did not affect either blood pressure or heart rate. In brain membranes from spontaneously 
<mark class="entity" style="background: linear-gradient(90deg, #fca9a9, #fcd59c); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    hypertensive
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Disease</span>
</mark>
 rats 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    clonidine
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Chemical</span>
</mark>
, 10(-8) to 10(-5) M, did not influence stereoselective binding of 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    [3H]-naloxone
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Chemical</span>
</mark>
 (8 nM), and 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    naloxone
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Chemical</span>
</mark>
, 10(-8) to 10(-4) M, did not influence 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    clonidine
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Chemical</span>
</mark>
-suppressible binding of 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    [3H]-dihydroergocryptine
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Chemical</span>
</mark>
 (1 nM). These findings indicate that in spontaneously 
<mark class="entity" style="background: linear-gradient(90deg, #fca9a9, #fcd59c); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    hypertensive
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Disease</span>
</mark>
 rats the effects of central alpha-adrenoceptor stimulation involve activation of opiate receptors. As 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    naloxone
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Chemical</span>
</mark>
 and 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    clonidine
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Chemical</span>
</mark>
 do not appear to interact with the same receptor site, the observed functional antagonism suggests the release of an endogenous opiate by 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    clonidine
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Chemical</span>
</mark>
 or 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    alpha-methyldopa
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">Chemical</span>
</mark>
 and the possible role of the opiate in the central control of sympathetic tone.</div>